Cure HHT wins inaugural Prix Galien Patient First Award
A patient-led initiative for rare disease hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix Galien Patient First Award.
TMS works. Why do fewer than 1% of eligible patients get it?
A growing body of clinical evidence suggests that TMS can produce response rates of roughly 50-60% or higher.
Ultragenyx gets first Euro nod for rare disease drug Dojolvi
Several years after its US approval, Ultragenyx's therapy for long-chain fatty acid oxidation disorders, Dojolvi, has been greenlit in the UK.
Reducing the risk of at-home chemo complications with remote...
Remote patient monitoring (RPM) of vitals takes away the uncertainty of leaving symptom detection to patients.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Evolution Summit 2027 to Convene Senior Clinical Development...
Westlake Village, CA: Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives
ISMAI 2026: Florence to host international symposium on the ...
On 3 and 4 December, in the CTO Auditorium of Careggi University Hospital, clinicians, scientists and international experts will discuss clinical judgement, patient safety and professional acco
11th Liquid Biopsy for Precision Oncology Summit West Coast
Your industry-leading, flagship West Coast meeting uniting the global liquid biopsy community
31st Edition Strategic Project & Portfolio Management for Ph...
The Marcus Evans 31st Edition Strategic Project & Portfolio Management for Pharma conference, for European pharmaceutical PMO and portfolio leaders.
Women in AI - an evening of practical AI learning
Women in AI returns November 10 in London, UK. Join women from across healthcare for an evening of practical AI learning.